GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Anlon Healthcare Ltd

Anlon Healthcare Ltd proposes Rs. 250 crore preferential issue

FUNDRAISE ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 13 Oct 2026, 09:52 PM IST  ·  BSE ID: 380393db-2894-45c6-8e33-b3b1e36b77da
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved a plan to get up to Rs. 250 crore by selling convertible warrants to select investors.
🤖 AI Summary
  • Anlon Healthcare board approved preferential issue of warrants for up to Rs. 250 crore.
  • Warrants are convertible into equity shares at a face value of Rs. 02/- each.
  • Promoter investors include Punitkumar Rameshbhai Rasadia and Meet Atulkumar Vachhani.
  • Public investors Smart Horizon Capital Advisors and Ploutos Plus Consultant are also included.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Aggregate amount for preferential issue
Rs.250,00,00,000/-
Face value of Equity Shares
Rs.02/-
🏢 How This Affects the Company
💰
Financial Impact
The preferential issue will inject up to Rs. 250 crore in cash consideration into the company upon conversion of warrants.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Further details on warrant price and meeting dates will follow.
👤
Who Is Affected
Existing shareholders will be affected by potential dilution upon conversion of warrants into equity shares.
🔍
Management Signal
Management intends to raise capital from a mix of promoters and public investors to fund company objectives.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Announcement of warrant price and conversion ratio.
Notice for shareholder meeting to approve the preferential issue.
Outcome of the shareholder meeting and subsequent regulatory filings.
MEDIUM RISK Potential equity dilution for existing shareholders upon warrant conversion.
💡 Investor Takeaway
Anlon Healthcare's board approved raising up to Rs. 250 crore through warrants convertible into equity, with specific promoters and public investors identified.
⚖️ Strengths & Concerns

✅ Positives

  • Board approval obtained for a significant fundraise of up to Rs. 250 crore via preferential issue.
  • Clear identification of both promoter and public investors for the proposed issuance of warrants.
❓ Frequently Asked Questions
What is the total amount Anlon Healthcare plans to raise?
Anlon Healthcare plans to raise an aggregate amount not exceeding Rs.250,00,00,000/- through a preferential issue.
What type of securities is Anlon Healthcare issuing?
The company is issuing warrants that are fully convertible into equivalent number of Equity Shares of face value of Rs.02/- each.
Who are the proposed investors for the preferential issue?
Proposed investors include promoters Punitkumar Rameshbhai Rasadia, Meet Atulkumar Vachhani, and public investors Smart Horizon Capital Advisors Private Limited and Ploutos Plus Consultant Private Limited.
What is the basis of the preferential issue?
The preferential issue will be undertaken for cash consideration in accordance with SEBI ICDR Regulations.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.